The global alosetron market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Alosetron the common name of alosetron and the product name isLotronex, it is a drug designed to treat women with Irritable Bowel Syndrome (IBS), and the effect of this is having diarrhea as a major problem. The increasing […]
